Medibank share price on watch amid class action and new data threat

Medibank shares closed in the green yesterday after the ASX 200 health insurer updated the market on its response to the October cyber breach.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • The Medibank share price is on watch
  • The ASX 200 insurer has been hit with a class action over the October data breach
  • Yesterday Medibank said it would not make any ransom payments

The Medibank Private Ltd (ASX: MPL) share price is on watch this morning.

This comes as news hits the wires that the S&P/ASX 200 Index (ASX: XJO) health insurer has been hit with a class action over the 12 October data breach.

Yesterday the Medibank share price finished up 0.4% after the company updated the market on its response to the data theft.

The company said the hacker had accessed the name, date of birth, address, phone number and email address of 9.7 million current and former customers along with some of their authorised representatives.

That group includes  5.1 million Medibank customers, 2.8 million AHM customers and 1.8 million international customers.

Medibank said it would not pay any ransom demands.

According to CEO David Koczkar:

Based on the extensive advice we have received from cybercrime experts we believe there is only a limited chance paying a ransom would ensure the return of our customers' data and prevent it from being published.

Today the company faces its first, but perhaps not last, class action over the incident.

This comes alongside news that the hackers have threatened to publish the customer data within 24 hours.

A man sits in casual clothes in front of a computer amid graphic images of data superimposed on the image, as though he is engaged in IT or hacking activities.

Image source: Getty Images

What's happening with the Medibank class action?

The Medibank share price is on watch after Bannister Law Class Actions and Centennial Lawyers reported they will jointly investigate the cyber breach.

In a statement released this morning, Bannister said (courtesy of The Sydney Morning Herald):

We believe the data breach is a betrayal of Medibank Private's customers and a breach of the Privacy Act. Medibank has a duty to keep this kind of information confidential.

The two firms will be investigating Medibank breached their privacy policy and the terms of their contract of the medical insurance which they provided to their customers. The lawyers will also assess whether damages should be paid to Medibank customers as a result of their breaches.

Medibank share price snapshot

The Medibank share price has come under significant pressure since the hacking attack was revealed. Shares are currently down 17.5% in 2022. That compares to an 8.6% year-to-date loss posted by the ASX 200.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A senior pharmacist talks to a customer at the counter in a shop.
Healthcare Shares

Broker sees 26% upside in ASX healthcare share behind Chemist Warehouse

Morgans has just upgraded its rating on this ASX healthcare stock due to ongoing share price weakness.

Read more »

Woman using a pen on a digital stock market chart in an office.
Healthcare Shares

Why this ASX healthcare stock is surging while the market sinks on Middle East fears

Avita shares surge as a US government contract boosts sentiment again

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Healthcare Shares

Should you buy Telix shares after its big US news?

Is this milestone a reason to invest? Let's find out.

Read more »

Three health professionals at a hospital smile for the camera.
Healthcare Shares

Up 31% in a month, why are Telix shares lifting off again on Friday?

ASX investors are piling into Telix shares today. But why?

Read more »

Doctor checking patient's spine x-ray image.
Healthcare Shares

Where is the value amongst ASX healthcare shares?

These three stocks are worth monitoring.

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Telix Pharmaceuticals: FDA accepts Pixclara NDA

The FDA has accepted Telix's Pixclara NDA for imaging brain cancer.

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Bell Potter says this ASX healthcare stock could rise nearly 200%

The positive announcement has reinforced the broker's recommendation.

Read more »

A man rests his chin in his hands, pondering what is the answer?
Healthcare Shares

CSL shares: 3 reasons to buy and 3 reasons to sell

CSL shares have tumbled again.

Read more »